Plasma BNP levels as a biomarker of hemodynamic outcome and mortality in cteph following pea

S. Surie, H. Reesink, J. Kloek, P. Bresser (Amsterdam, Netherlands)

Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Session: Acute and chronic venous thromboembolic disease
Session type: Oral Presentation
Number: 2778
Disease area: Pulmonary vascular diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Surie, H. Reesink, J. Kloek, P. Bresser (Amsterdam, Netherlands). Plasma BNP levels as a biomarker of hemodynamic outcome and mortality in cteph following pea. Eur Respir J 2009; 34: Suppl. 53, 2778

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Procalcitonin and C-reactive protein levels correlate worse with organ failure than NT-proBNP levels in septic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 61s
Year: 2006

Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


EBC glucose levels predict adverse outcome in ARDS
Source: Eur Respir J 2006; 28: Suppl. 50, 183s
Year: 2006

Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010

Circulating fetuin-A as a biomarker predicting mortality in ICU septic patients
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017


Can serum cortisol levels predict weaning and extubation outcome?
Source: Annual Congress 2007 - Mechanical ventilation and airways
Year: 2007


Elevated serum high-sensitivity cardiac troponin I is related to mortality in COPD
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Usefulness of troponin-1, lactate and c-reactive protein as a prognostic markers in critically ill, non cardiac patients
Source: Eur Respir J 2005; 26: Suppl. 49, 436s
Year: 2005

Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Admission serum glucose levels are a risk factor predicting short- and long-term mortality in community acquired pneumonia
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012


Circulating total leptin as a diagnostic and prognostic biomarker in sepsis
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019


Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005

Elevated plasma EPCR levels early post ICU admission predict sepsis development
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010


Clinical relevance of peri-operative IL-6 plasma levels in heart valve surgery
Source: Eur Respir J 2006; 28: Suppl. 50, 60s
Year: 2006

Usefulness of troponin-I, lactate, C-reactive protein as a prognostic markers in critically ill non-cardiac patients
Source: Eur Respir J 2006; 28: Suppl. 50, 181s
Year: 2006

Plasma levels of NT-proBNP in OSAS patients before CPAP treatment. Relationship to ventricular dysfunction. Preliminary results
Source: Eur Respir J 2006; 28: Suppl. 50, 415s
Year: 2006

Serum CC16 is a potential predictor for IPF diagnosis and prognosis
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Dynamic changes of serum sTREM-1 and its gene polymorphisms associated with sepsis prognosis
Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections
Year: 2012